University of Pennslyvania Health Systems
Office of Public Affairs
399 South 34th Street, Suite 2002, Penn Tower, Philadelphia, PA 19104-5653

Susan Winston, 215-349-8368,

July 31, 2003

Chrysalyne D. Schmults, MD, Appointed Assistant Professor of Dermatology at the University of Pennsylvania School of Medicine

(Philadelphia, PA) -- Chrysalyne D. Schmults, MD, has been appointed Assistant Professor in the Department of Dermatology, at the University of Pennsylvania School of Medicine.

Dr. Schmults earned her medical degree from Yale University School of Medicine and completed an internship in Medicine at Stanford University Medical Center. She took her residency in Dermatology at New York University. While there she became a clinical instructor of Dermatology at the School of Medicine, and a Chief Resident. These appointments afforded her the opportunity to re-structure the residents' curriculum to include additional emphasis on advanced topics in dermatology. Dr. Schmults then went on to complete a fellowship in Mohs' micrographic surgery and skin laser medicine at Skin Laser and Surgery Specialists of NY/NJ.

Schmults' initial research will focus on investigating the efficacy and safety of topical, non-surgical treatments for basal and squamous cell carcinomas - two of the most common types of skin cancer. Her clinical responsibilities will include Mohs' surgery, an advanced surgical procedure used for recurrent skin cancers, as well as primary cancers that are on the face or that do not respond to other therapies. It involves removing all cancerous tissue, while sparing the greatest amount of healthy tissue. Use of the Mohs' technique yields the highest cure rate available for basal and squamous carcinomas.

Dr. Schmults is currently an editorial reviewer for the Journal of Drugs in Dermatology; and as a co-author, has been published in peer-reviewed publications and book chapters including the Journal of Ambulatory Surgery, Journal of Cellular Physiology, Careers in Dermatology, and Current Dermatologic Diagnosis and Treatment.

# # #

PENN Medicine is a $2.2 billion enterprise dedicated to the related missions of medical education, biomedical research, and quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System (created in 1993 as the nation's first integrated academic health system).

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH funds; and ranked #4 in the nation in U.S .News & World Report's recent ranking of top research-oriented medical schools. Supporting 1400 full-time faculty and 700 students, Penn's School of Medicine is recognized worldwide for its superior education and training of the next generation of physician/scientists and leaders of academic medicine. Penn's Health System consists of four hospitals (including its flagship Hospital of the University of Pennsylvania, consistently rated one of the nation's "Honor Roll" hospitals by U.S. News & World Report); a faculty practice plan, a primary-care provider network, three multispecialty satellite facilities, and home healthcare and hospice.

Release and photograph are available online at